Medicale Corp. - Understand $mcle stock

$MCLE Market Cap: $1.894 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$0.00

TTM

Gross Margin

Net Earnings

-$55.56K

TTM

Current Assets

$159.00

Q2 2024

Current Liabilities

$14.14K

Q2 2024

Current Ratio

1.12%

Q2 2024

Total Assets

$159.00

Q2 2024

Total Liabilities

$82.21K

Q2 2024

Book Value

-$82.05K

Q2 2024

Cash

$159.00

Q2 2024

P/E

-34.09

Nov 29, 2024 EST

Free Cash Flow

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020
Revenue	$0.00	$0.00	$0.00	$0.00
YoY Change

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020
Revenue	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020
Selling, General & Admin	$37.59K	$46.42K	$32.15K	$1.920K
YoY Change	-19.02%	44.39%	1574.48%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$2.400K	$2.400K
YoY Change		0.0%
% of Gross Profit
Operating Expenses	$37.59K	$46.42K	$32.15K	$1.920K
YoY Change	-19.01%	44.38%	1574.48%
Operating Profit	-$37.59K	-$46.42K	-$32.15K
YoY Change	-19.01%	44.37%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020
Pretax Income	-$37.59K	-$46.42K	-$32.15K	-$1.920K
YoY Change	-19.01%	44.38%	1574.48%
Income Tax	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$37.14K	-$46.42K	-$32.15K	-$1.920K
YoY Change	-19.99%	44.38%	1574.48%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01	-$0.01	-$0.01
Diluted Earnings Per Share	-$0.01	-$0.01	-$9.456K	-$564.70

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020
Cash & Short-Term Investments	$160.00	$0.00	$18.48K
YoY Change		-100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$160.00	$0.00	$18.68K	$200.00
YoY Change		-100.0%	9240.0%
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$9.600K	$12.00K
YoY Change		-100.0%	-20.0%
Total Assets	$160.00	$0.00	$28.28K	$12.20K
YoY Change
Accounts Payable	$8.400K	$37.00K	$25.00K	$13.00K
YoY Change	-77.3%	48.0%	92.31%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$40.88K	$54.77K	$36.63K	$13.60K
YoY Change	-25.36%	49.52%	169.34%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00	$0.00
YoY Change
Total Liabilities	$40.88K	$54.77K	$36.63K	$13.60K
YoY Change	-25.36%	49.52%	169.34%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021
Basic Shares Outstanding	5.920M shares	5.920M shares	3.616M shares
Diluted Shares Outstanding	5.920M shares	5.920M shares	3.616M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $1.8942 Million

About Medicale Corp.

Medicale Corp. engages in the provision of consulting services and distribution of dietary supplements. The company is headquartered in Wellington Florida, Florida. The company went IPO on 2021-11-19. The dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid. The supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, to enhance the quantity of their consumption. The firm has not commenced any operations.

Industry: Services-Health Services Peers: